Vimta Labs Ltd - Stock Valuation and Financial Performance

BSE: 524394 | NSE: VIMTALABS | Pharmaceuticals & Drugs | Small Cap

Vimta Labs Share Price

445 -11.20 -2.46%
as on 28-Mar'24 16:01

DeciZen - make an informed investing decision on Vimta Labs

Overall Rating
Bole Toh

1. Quality

2. Valuation

Somewhat overvalued

3. Price Trend

Vimta Labs stock performance -

mw4me loader
P/E Ratio (SA):
25.76
Market Cap:
1,011.4 Cr.
52-wk low:
294
52-wk high:
621.4

Is Vimta Labs Ltd an attractive stock to invest in?

1. Is Vimta Labs Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Vimta Labs Ltd is a average quality company.

2. Is Vimta Labs Ltd undervalued or overvalued?

The key valuation ratios of Vimta Labs Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.

3. Is Vimta Labs Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Vimta Labs Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Vimta Labs:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Vimta Labs Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Value Creation Index Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % 10.8%4.2%5.2%7.5%10.9%14.4%4.2%10.8%18.1%17.6%-
Value Creation
Index
-0.2-0.7-0.6-0.5-0.20.0-0.7-0.20.30.3-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 118107125154183213181209276315315
Sales YoY Gr.--9.3%16.3%23.4%19.2%15.9%-15%15.7%32%14.2%-
Adj EPS 5.42.22.957.511.32.69.8192117.7
YoY Gr.--59.3%31.5%71.9%51.9%49.7%-76.7%272.1%95%10.4%-
BVPS (₹) 54.555.35761.668.877.678.287.9104.4123.9137.1
Adj Net
Profit
11.94.86.410.916.624.95.821.64246.539
Cash Flow from Ops. 16.815.3-123.933.439.324.43758.786.5-
Debt/CF from Ops. 0.40.2-25.61.81.20.71.30.80.30.2-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 11.5%11.4%20.4%14.2%
Adj EPS 16.3%22.8%100.1%10.4%
BVPS9.6%12.5%16.6%18.7%
Share Price 23.2% 17.7% 42.8% 47.8%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
10.245.18.311.515.43.411.719.618.113.6
Op. Profit
Mgn %
2216.215.218.124.827.216.625.42929.726.5
Net Profit
Mgn %
10.14.55.17.19.111.73.210.315.214.712.4
Debt to
Equity
0.100.20.30.30.20.20.20.10.1-
Working Cap
Days
15718719918716815819518615814893
Cash Conv.
Cycle
861121189992101128113959260

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 20.37%

Net Profit is growing at healthy rate in last 3 years 100.10%

Return on Equity has declined versus last 3 years average to 13.60%

Sales growth is not so good in last 4 quarters at 2.57%

Latest Financials - Vimta Labs Ltd.

Standalone Consolidated
TTM EPS (₹) 17.7 18.7
TTM Sales (₹ Cr.) 315 320
BVPS (₹.) 137.1 138.4
Reserves (₹ Cr.) 300 302
P/BV 3.33 3.30
PE 25.76 24.47
From the Market
52 Week Low / High (₹) 293.95 / 621.40
All Time Low / High (₹) 0.20 / 621.40
Market Cap (₹ Cr.) 1,011
Equity (₹ Cr.) 4.4
Face Value (₹) 2
Industry PE 47.8

Management X-Ray of Vimta Labs:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Vimta Labs

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales118107125154183213181209276315
Operating Expenses 9290106127138155151156196222
Manufacturing Costs48465359596863689087
Material Costs1-3002-10300
Employee Cost 25293343495558577186
Other Costs 18181924283329283649
Operating Profit 26171927455830538094
Operating Profit Margin (%) 21.9%16.2%15.1%17.8%24.7%27.1%16.6%25.2%28.9%29.7%
Other Income 3111123113
Interest 2112554213
Depreciation 9111010162021232331
Exceptional Items 00000000-10
Profit Before Tax 18781726358285564
Tax 4226910171417
Profit After Tax 13561116257214147
PAT Margin (%) 11.2%4.7%5.2%6.9%9.0%11.9%3.8%10.2%14.9%15.0%
Adjusted EPS (₹)6.02.32.94.87.411.53.19.618.621.4
Dividend Payout Ratio (%)33%44%34%0%27%17%0%21%11%9%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 120122126136152172173194231274
Share Capital 4444444444
Reserves 116118122132148167169190226270
Minority Interest0000000000
Debt742637331722221310
Long Term Debt00161819125141310
Short Term Debt74101913518800
Trade Payables57615131110151214
Others Liabilities 17141833353839414958
Total Liabilities 149146176222232237244272304356

Fixed Assets

Gross Block21222223198166180197216266300
Accumulated Depreciation1221341431025456688105133
Net Fixed Assets90888888140135131128162168
CWIP 2065304217012
Investments 0000006666
Inventories11161615181917151723
Trade Receivables28263842565958737780
Cash Equivalents 413133771139
Others Assets14152522151824263028
Total Assets 149146176222232237244272304356

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity 1715-124333924375987
PBT 18781726358285564
Adjustment 11121112233023293139
Changes in Working Capital -8-1-191-9-16-1-13-11-4
Tax Paid -4-1-2-5-6-10-6-7-17-12
Cash Flow From Investing Activity -8-8-16-39-24-16-20-32-38-57
Capex -8-8-16-40-24-16-14-32-39-50
Net Investments 000000010-9
Others 000011-6011
Cash Flow From Financing Activity -8-91913-8-23-1-5-16-11
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 001682-7-67-3-5
Interest Paid -20-1-2-4-3-2-2-1-1
Dividend Paid -2-4-2-30-5-50-4-4
Others -5-469-6-812-9-80
Net Cash Flow 0-12-21131519
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)11.384.175.188.0811.415.644.0211.5819.3218.73
ROCE (%)15.945.826.9511.2216.5520.426.0114.2423.8524.25
Asset Turnover Ratio0.810.730.770.770.810.910.750.810.960.95
PAT to CFO Conversion(x)1.313-0.172.182.061.563.431.761.441.85
Working Capital Days
Receivable Days8392939598981171149991
Inventory Days34454637333237282123
Payable Days4,327-778002,187-5,63101,51700

Vimta Labs Ltd Stock News

Vimta Labs Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Vimta Labs on 28-Mar-2024 16:01 is ₹445.0.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 28-Mar-2024 16:01 the market cap of Vimta Labs stood at ₹1,011.4.
The latest P/E ratio of Vimta Labs as of 28-Mar-2024 16:01 is 25.76.
The latest P/B ratio of Vimta Labs as of 28-Mar-2024 16:01 is 3.33.
The 52-week high of Vimta Labs is ₹621.4 and the 52-week low is ₹293.9.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Vimta Labs is ₹315.4 ( Cr.) .

About Vimta Labs Ltd

Vimta Labs is India’s leading contract research and testing organization. Established in 1984, Vimta has an envious track record of serving several market leaders across the globe.

Vimta supports regulatory authorities in mandatory certification of food and agri products exported from India. Vimta assists the food industry commissions for nutritional labelling, food safety evaluations, trace analysis and shelf life studies.

Vimta has a team of 684 professionals comprising 446 scientists in various disciplines such as chemistry, pharma, medicine, microbiology, molecular biology and informatics. The team is slated to double in next three years.

Vimta is a multi-site organization with more than 300,000 sqft world class laboratory facilities. The technologies deployed at Vimta are current and leading edge, duly validated.

Vimta has over 12 years of experience in providing preclinical services to Pharma companies world-wide accordance with the guidelines prescribed by international agencies.

Vimta has a state-of-art building of Class 10,000 Pre-clinical facility with a total built up area of 33,000 sq.ft. with 32 rodent experimental rooms, 5 procedure rooms, separate quarantine facility and distinct non-rodent facility with 48 SS kennels with a comfortable perch, liberal exercise area.

It provides services in pharmacology, toxicology and DMPK areas. The toxicology services include but not limited to in-vivo and in-vitro genotoxicity, acute to chronic toxicity, carcinogenicity, reproductive toxicity studies, safety pharmacology, and immunotoxicology. Pharmacology services are available in various therapeutics areas such as pain & inflammation, metabolic disorders, respiratory, CNS, and xenograft & allograft models for oncology. In addition to the regulatory studies we use tailor-made in vitro and in vivo ADME techniques to help profile your drug candidate in both rodent and non-rodent animals models.

Services offered by the company:

  • Advanced Molecular Biology
  • Food and Agriculture
  • Drugs & Pharma
  • Water
  • Environmental Assessments
  • Clinical Research
  • Clinical Reference Lab Services
  • Preclinical Research
  • Genomics Online Ordering

 Achievements/ recognition

  •    NABL as per ISO 15189:2007
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.